9alpha-angeloyloxyludovicin A - Compound Card

9alpha-angeloyloxyludovicin A

Select a section from the left sidebar

9alpha-angeloyloxyludovicin A

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene Lactone
Canonical Smiles C/C=C(\C(=O)O[C@@H]1CC2[C@H](C)C(=O)O[C@@H]2[C@@H]2[C@]1(C)[C@@H](O)C[C@@H]1[C@@]2(C)O1)/C
InChI InChI=1S/C20H28O6/c1-6-9(2)17(22)24-13-7-11-10(3)18(23)25-15(11)16-19(13,4)12(21)8-14-20(16,5)26-14/h6,10-16,21H,7-8H2,1-5H3/b9-6-/t10-,11?,12-,13+,14+,15-,16+,19+,20+/m0/s1
InChIKey JHAYXWWXUGLOHK-QGBCZBPOSA-N
Formula C20H28O6
HBA 6
HBD 1
MW 364.44
Rotatable Bonds 2
TPSA 85.36
LogP 1.99
Number Rings 4
Number Aromatic Rings 0
Heavy Atom Count 26
Formal Charge 0
Fraction CSP3 0.8
Exact Mass 364.19
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Pluchea dioscoridis Asteraceae Plantae

Showing of synonyms

  • Bohlmann F, Metwally MA, et al. (1984). Eudesmanolides from Pluchea dioscoridis. Phytochemistry,1984,23(9),1975-1977. [View]
Pubchem: 162816874
Nmrshiftdb2: 70059451

No compound-protein relationship available.

Structure

SMILES: C12C(O2)CCC3C1C4C(CC(=O)O4)CC3

Level: 0

Mol. Weight: 364.44 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.12
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.71
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.36

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.36
Plasma Protein Binding
38.04
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
15.0
Organic Cation Transporter 2
Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Toxic
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.19
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-0.6
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.66
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-7.8
Rat (Acute)
4.13
Rat (Chronic Oral)
1.54
Fathead Minnow
3.92
Respiratory Disease
Toxic
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
404.88
Hydration Free Energy
-5.54
Log(D) at pH=7.4
1.39
Log(P)
2.3
Log S
-2.95
Log(Vapor Pressure)
-7.01
Melting Point
134.04
pKa Acid
6.35
pKa Basic
4.35
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Soluble acetylcholine receptor Q8WSF8 Q8WSF8_APLCA Aplysia californica 3 0.7758
Soluble acetylcholine receptor Q8WSF8 Q8WSF8_APLCA Aplysia californica 3 0.7758
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7358
Lactoylglutathione lyase Q9CPU0 LGUL_MOUSE Mus musculus 2 0.7358

Download SDF